Effect of intraoperative HES 6% 130/0.4 on the need for blood transfusion after major oncologic surgery: a propensity-matched analysis

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorZAMPIERI, Fernando Godinho
dc.contributor.authorRANZANI, Otavio T.
dc.contributor.authorMORATO, Priscila Fernanda
dc.contributor.authorCAMPOS, Pedro Paulo
dc.contributor.authorCARUSO, Pedro
dc.date.accessioned2013-09-23T16:50:41Z
dc.date.available2013-09-23T16:50:41Z
dc.date.issued2013
dc.description.abstractOBJECTIVES: To evaluate the effect of the intraoperative use of hydroxyethyl starch on the need for blood products in the perioperative period of oncologic surgery. The secondary end-points included the need for other blood products, the clotting profile, the intensive care unit mortality and length of stay. METHODS: Retrospective observational analysis in a tertiary oncologic ICU in Brazil including 894 patients submitted to oncologic surgery for a two-year period from September 2007. Patients were grouped according to whether hydroxyethyl starch was used during surgery (hydroxyethyl starch and No-hydroxyethyl starch groups) and compared using a propensity score analysis. A total of 385 propensity-matched patients remained in the analysis (97 in the No-hydroxyethyl starch group and 288 in the hydroxyethyl starch group). RESULTS: A higher percentage of patients in the hydroxyethyl starch group required red blood cell transfusion during surgery (26% vs. 14%; p = 0.016) and in the first 24 hours after surgery (5% vs. 0%; p = 0.015) but not in the 24-to 48-hour period after the procedure. There was no difference regarding the transfusion of other blood products, intensive care unit mortality or length of stay. CONCLUSION: Hydroxyethyl starch use in the intraoperative period of major oncologic surgery is associated with an increase in red blood cell transfusions. There are no differences in the need for other blood products, intensive care unit length of stay or mortality.
dc.description.indexMEDLINE
dc.identifier.citationCLINICS, v.68, n.4, p.501-509, 2013
dc.identifier.doi10.6061/clinics/2013(04)11
dc.identifier.issn1807-5932
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/2302
dc.language.isoeng
dc.publisherHOSPITAL CLINICAS, UNIV SAO PAULO
dc.relation.ispartofClinics
dc.rightsopenAccess
dc.rights.holderCopyright HOSPITAL CLINICAS, UNIV SAO PAULO
dc.subjectTetrastarch
dc.subjectAdverse Events
dc.subjectBlood Transfusion
dc.subjectSurgical Blood Loss
dc.subjectSurgery
dc.subjectCancer
dc.subject.otherhydroxyethyl starch 130/0.4
dc.subject.othercritically-ill patients
dc.subject.otherplasma-volume expansion
dc.subject.othersevere sepsis
dc.subject.otherorthopedic-surgery
dc.subject.othercardiac response
dc.subject.othercancer-patients
dc.subject.otherscore methods
dc.subject.otherlung-cancer
dc.subject.otherresuscitation
dc.subject.wosMedicine, General & Internal
dc.titleEffect of intraoperative HES 6% 130/0.4 on the need for blood transfusion after major oncologic surgery: a propensity-matched analysis
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.author.externalZAMPIERI, Fernando Godinho:Hosp Canc AC Camargo, Intens Care Unit, Sao Paulo, Brazil; Univ Sao Paulo, Fac Med, Emergency Med Discipline, Intens Care Unit, Sao Paulo, Brazil; Hosp Alemao Oswaldo Cruz, Intens Care Unit, Sao Paulo, Brazil
hcfmusp.author.externalMORATO, Priscila Fernanda:Hosp Canc AC Camargo, Intens Care Unit, Sao Paulo, Brazil
hcfmusp.author.externalCAMPOS, Pedro Paulo:Hosp Canc AC Camargo, Intens Care Unit, Sao Paulo, Brazil
hcfmusp.citation.scopus3
hcfmusp.contributor.author-fmusphcOTAVIO TAVARES RANZANI
hcfmusp.contributor.author-fmusphcPEDRO CARUSO
hcfmusp.description.beginpage501
hcfmusp.description.endpage509
hcfmusp.description.issue4
hcfmusp.description.volume68
hcfmusp.origemWOS
hcfmusp.origem.pubmed23778341
hcfmusp.origem.scieloSCIELO:S1807-59322013000400501
hcfmusp.origem.scopus2-s2.0-84878148635
hcfmusp.origem.wosWOS:000320002000011
hcfmusp.publisher.citySAO PAULO
hcfmusp.publisher.countryBRAZIL
hcfmusp.relation.referenceAbosaif NY, 2005, AM J KIDNEY DIS, V46, P1038, DOI 10.1053/j.ajkd.2005.08.033
hcfmusp.relation.referenceAmar D, 2003, ANESTHESIOLOGY, V98, P337, DOI 10.1097/00000542-200302000-00011
hcfmusp.relation.referenceAustin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786
hcfmusp.relation.referenceBellmann R, 2012, CLIN PHARMACOKINET, V51, P225, DOI 10.2165/11594700-000000000-00000
hcfmusp.relation.referenceBrookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149
hcfmusp.relation.referenceBrookhart MA, 2006, EPIDEMIOLOGY, V17, P373, DOI 10.1097/01.ede.0000222026.42077.ee
hcfmusp.relation.referenceBrunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716
hcfmusp.relation.referenceCorcoran T, 2012, ANESTH ANALG, V114, P640, DOI 10.1213/ANE.0b013e318240d6eb
hcfmusp.relation.referenceD'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B
hcfmusp.relation.referencede Jonge E, 2001, CRIT CARE MED, V29, P1261, DOI 10.1097/00003246-200106000-00038
hcfmusp.relation.referenceDoherty M, 2012, BRIT J ANAESTH, V109, P69, DOI 10.1093/bja/aes171
hcfmusp.relation.referenceDrews RE, 2003, CLIN CHEST MED, V24, P607, DOI 10.1016/S0272-5231(03)00100-X
hcfmusp.relation.referenceDubniks M, 2007, INTENS CARE MED, V33, P293, DOI 10.1007/s00134-006-0454-5
hcfmusp.relation.referenceFranz A, 2001, ANESTH ANALG, V92, P1402
hcfmusp.relation.referenceGattas DJ, 2012, ANESTH ANALG, V114, P159, DOI 10.1213/ANE.0b013e318236b4d6
hcfmusp.relation.referenceGayat E, 2010, INTENS CARE MED, V36, P1993, DOI 10.1007/s00134-010-1991-5
hcfmusp.relation.referenceGuidet B, 2012, CRIT CARE, V16, DOI 10.1186/cc11358
hcfmusp.relation.referenceHahn RG, 2010, ANESTHESIOLOGY, V113, P470, DOI 10.1097/ALN.0b013e3181dcd88f
hcfmusp.relation.referenceHartog CS, 2011, INTENS CARE MED, V37, P1725, DOI 10.1007/s00134-011-2385-z
hcfmusp.relation.referenceHartog CS, 2011, ANESTH ANALG, V112, P635, DOI 10.1213/ANE.0b013e31820ad607
hcfmusp.relation.referenceHayden SJ, 2012, AM J RESP CRIT CARE, V185, P1049, DOI 10.1164/rccm.201110-1915CI
hcfmusp.relation.referenceJames MFM, 2011, BRIT J ANAESTH, V107, P693, DOI 10.1093/bja/aer229
hcfmusp.relation.referenceKomatsu Y, 2012, WORLD J SURG, V36, P844, DOI 10.1007/s00268-012-1433-3
hcfmusp.relation.referenceKozek-Langenecker SA, 2005, ANESTHESIOLOGY, V103, P654, DOI 10.1097/00000542-200509000-00031
hcfmusp.relation.referenceKozek-Langenecker SA, 2008, ANESTH ANALG, V107, P382, DOI 10.1213/ane.0b013e31817e6eac
hcfmusp.relation.referenceKvolik S, 2010, SURG ONCOL, V19, pE33, DOI 10.1016/j.suronc.2009.03.008
hcfmusp.relation.referenceLangeron O, 2001, ANESTH ANALG, V92, P855
hcfmusp.relation.referenceLobo SM, 2011, CRIT CARE, V15, DOI 10.1186/cc10466
hcfmusp.relation.referenceMiletin MS, 2002, INTENS CARE MED, V28, P917, DOI 10.1007/s00134-002-1337-z
hcfmusp.relation.referenceNg T, 2012, J THORAC CARDIOV SUR, V143, P815, DOI 10.1016/j.jtcvs.2011.12.031
hcfmusp.relation.referencePerel P, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub4
hcfmusp.relation.referencePerisanidis C, 2012, ORAL ONCOL, V48, P372, DOI 10.1016/j.oraloncology.2011.11.020
hcfmusp.relation.referencePerner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242
hcfmusp.relation.referencePersson J, 2006, CRIT CARE MED, V34, P2456, DOI 10.1097/01.CCM.0000233876.87978.AB
hcfmusp.relation.referenceProwle JR, 2011, CRIT CARE, V15, DOI 10.1186/cc10318
hcfmusp.relation.referenceRzyman W, 2003, J THORAC CARDIOV SUR, V126, P755, DOI 10.1016/S0022-5223(03)00217-4
hcfmusp.relation.referenceSchortgen F, 2004, INTENS CARE MED, V30, P2222, DOI 10.1007/s00134-004-2415-1
hcfmusp.relation.referenceSchramko A, 2010, BRIT J ANAESTH, V104, P691, DOI 10.1093/bja/aeq084
hcfmusp.relation.referenceSinger M, 2012, CURR OPIN ANESTHESIO, V25, P96, DOI 10.1097/ACO.0b013e32834e8150
hcfmusp.relation.referenceSossdorf M, 2009, CRIT CARE, V13, DOI 10.1186/cc8223
hcfmusp.relation.referenceTrof RJ, 2010, INTENS CARE MED, V36, P697, DOI 10.1007/s00134-010-1776-x
hcfmusp.relation.referenceVerheij J, 2006, INTENS CARE MED, V32, P1030, DOI 10.1007/s00134-006-0195-5
hcfmusp.relation.referenceWestphal M, 2009, ANESTHESIOLOGY, V111, P187, DOI 10.1097/ALN.0b013e3181a7ec82
hcfmusp.scopus.lastupdate2024-05-17
relation.isAuthorOfPublicationff868d73-8d06-4d14-8c2a-2d8704871e0b
relation.isAuthorOfPublication2197b16c-5e35-406d-b33f-ba81fbf26ae2
relation.isAuthorOfPublication.latestForDiscoveryff868d73-8d06-4d14-8c2a-2d8704871e0b
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
art_RANZANI_Effect_of_intraoperative_HES_6%_130_0_4_2013.PDF
Tamanho:
415.91 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/09
Artigos e Materiais de Revistas Científicas - ODS/03